Top Story

Urinary adiponectin predicts diabetic nephropathy progression in type 1 diabetes

February 27, 2015

Urinary adiponectin strongly and independently predicted the progression of diabetic nephropathy from macroalbuminuria to end-stage renal disease in patients with type 1 diabetes, according to research published in Diabetes Care.

The findings on urinary adiponectin (uADP) provide added predictive benefit to current biomarkers including albumin excretion rates (AER) and estimated glomerular filtration rates, according to researchers.  

In the Journals

Diabetes, CVD increase rates of CV events

February 27, 2015
Among adults with diabetes, paying extra attention to traditional cardiovascular risk factors could reduce the rates of cardiovascular events and mortality, according to…
In the Journals

CVD risk assessment priority for adults with diabetes, metabolic syndrome

February 26, 2015
Approximately one-quarter of adults with type 2 diabetes and metabolic syndrome face a cardiovascular disease risk of at least 20%, according to research published in…
In the Journals

Statin use may reduce risk for liver cancer

February 26, 2015
The use of statins decreased the risk for primary liver cancer, especially in patients with liver disease and diabetes, according to newly published data. “The…
CME
Improving Outcomes with SGLT2 Contransporter Inhibitors in Challenging T2DM Patients

Improving Outcomes with SGLT2 Contransporter Inhibitors in Challenging T2DM Patients - Monograph

This activity is supported by an educational grant from Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC

Recent advances with novel orally administered SGLT2 cotransporter inhibitors, a new class of antidiabetes agents that…
More »
Meeting News Coverage Video
Healio CMHC2014 Ferdinand2 th

Keith C. Ferdinand, MD, highlights recent data on link between CVDs, diabetes drugs

October 30, 2014
BOSTON — At the Cardiometabolic Health Congress, Keith C. Ferdinand, MD, FACC, professor of clinical medicine at…
More »
CME
Improving Outcomes

Improving Outcomes with SGLT2 Cotransporter Inhibitors in Challenging T2DM Patients: Updates from EASD 2013

This activity is supported by an educational grant from Janssen Pharmaceuticals.

Recent advances with novel orally administered SGLT2 cotransporter inhibitors, a new class of antidiabetes agents that…
More »
In the Journals

Urinary adiponectin predicts diabetic nephropathy progression in type 1 diabetes

February 27, 2015
Urinary adiponectin strongly and independently predicted the progression of diabetic nephropathy from macroalbuminuria to end-stage renal disease in…
In the Journals

Diabetes, CVD increase rates of CV events

February 27, 2015
Among adults with diabetes, paying extra attention to traditional cardiovascular risk factors could reduce the rates of cardiovascular events and…
In the Journals

CVD risk assessment priority for adults with diabetes, metabolic syndrome

February 26, 2015
Approximately one-quarter of adults with type 2 diabetes and metabolic syndrome face a cardiovascular disease risk of at least 20%, according to…
In the Journals

Statin use may reduce risk for liver cancer

February 26, 2015
The use of statins decreased the risk for primary liver cancer, especially in patients with liver disease and diabetes, according to newly published…
FDA News

FDA requires warning to prohibit sharing of multi-dose diabetes pens

February 26, 2015
The FDA is requiring additional label warnings on multi-dose diabetes pen devices prohibiting the sharing of the injectable medicines to reduce the…
FDA News

Sanofi gains FDA approval for Toujeo once-daily basal insulin

February 26, 2015
The FDA late Wednesday approved a once-daily, long-acting basal insulin with recombinant DNA technology to improve glycemic control in adults with…
In the Journals

Low parental income boosts mortality risk in childhood-onset type 1 diabetes

February 25, 2015
Exposure to low socioeconomic status, reflected in the need for income support, appears to increase the risk for death in patients diagnosed with…
In the Journals

High energy breakfast improves all-day glucose control in patients with type 2 diabetes

February 25, 2015
Adults with type 2 diabetes achieved better blood glucose control with a high-energy breakfast and low-energy dinner than a low-energy breakfast and…
In the Journals

Addressing stress, change in commitments may improve diabetes control

February 24, 2015
When promoting self-care understanding and diet adherence for patients with type 2 diabetes, clinicians should be aware of the negative impact the…
In the Journals

Vitamin D deficits more closely related to diabetes than to obesity

February 23, 2015
Diminished levels of vitamin D in adults with prediabetes and diabetes, occurring regardless of BMI, suggest the deficiency is more related to…
More Headlines »
morganatic-roan